SlideShare a Scribd company logo
Dr Dheeraj sharma 
M.Ch (CTVS) Resident
 Sir Thomas Lauder Brunton, a Scottish physician, first 
introduced the concept of surgical repair of the mitral 
valve in 1902. 
 Elliot Cutler ,Professor of Surgery at the Peter Bent 
Brigham Hospital in Boston, performed the world’s 
first successful mitral valve operation in 1923 by 
carrying out a transventricular commissurotomy with 
a neurosurgical tenotomy knife. 
 Henry Souttar of England performed a single 
successful transatrial finger commissurotomy in 1925. 
 Surgical treatment of mitral regurgitation for prolapse 
was first introduced in the 1950s.
 Harold and kay obliterated the commisures using 
sequence of mattress sutures. 
 Paneth and devega did the annuloplasty by taking 
the circumferential sutures around the annulus. 
 In 1960 McGoon proposed the resection of part of 
leaflets with ruptured chordae as a part of repair. 
 Carpentier and Duran started the use of 
prosthetic rings to remodel the mitral valve 
annulus.
Organic 
• Degenerative 
• Barlow’s 
• Dystrophic 
• Marfan’s 
• Other 
• Endocarditis 
• Rheumatic 
• Post-traumatic 
Functional 
• Ischemic 
• DCM
RECOMMENDATION COR LOE 
MV surgery is recommended for symptomatic patients with 
I B 
chronic severe primary MR (stage D) and LVEF >30% 
MV surgery is recommended for asymptomatic patients with 
chronic severe primary MR and LV dysfunction (LVEF 30%– 
60% and/or LVESD ≥40 mm, stage C2) 
I B 
MV repair is recommended in preference to MVR when 
surgical treatment is indicated for patients with chronic severe 
primary MR limited to the posterior leaflet 
I B 
MV repair is recommended in preference to MVR when 
surgical treatment is indicated for patients with chronic severe 
primary MR involving the anterior leaflet or both leaflets when 
a successful and durable repair can be accomplished 
I B 
Concomitant MV repair or replacement is indicated in patients 
with chronic severe primary MR undergoing cardiac surgery 
for other indications . 
I B
MV repair is reasonable in asymptomatic patients with chronic severe 
primary MR (stage C1) with preserved LV function (LVEF >60% and 
LVESD <40 mm) in whom the likelihood of a successful and durable repair 
without residual MR is >95% with an expected mortality rate of 
<1% when performed at a Heart Valve Center of Excellence 
IIA B 
MV repair is reasonable for asymptomatic patients with chronic severe 
nonrheumatic primary MR (stage C1) and preserved LV function in whom 
there is a high likelihood of a successful and durable repair with 1) new onset 
of AF or 2) resting pulmonary hypertension (PA systolic arterial pressure >50 
mm Hg) 
IIA B 
Concomitant MV repair is reasonable in patients with chronic moderate 
primary MR (stage B) undergoing cardiac surgery for other indications 
IIA C 
MV surgery may be considered in symptomatic patients with chronic severe 
primary MR and LVEF 30% (stage D) 
IIB C 
MV repair may be considered in patients with rheumatic mitral valve disease 
when surgical treatment is indicated if a durable and successful repair is 
likely or if the reliability of long-term anticoagulation management is 
questionable 
IIB B 
Transcatheter MV repair may be considered for severely symptomatic 
patients (NYHA class III/IV) with chronic severe primary MR (stage D) who 
have a reasonable life expectancy but a prohibitive surgical risk because of 
severe comorbidities 
IIB B 
MVR should not be performed for treatment of isolated severe primary MR 
limited to less than one half of the posterior leaflet unless MV repair has been 
attempted and was unsuccessful 
III B
 1. mitral valve replacement. 
 2. mitral valve repair
• Better preservation of LV function 
• Avoidance of prosthesis related events(hazards of 
anticoagulation, stroke, endocarditis, short life 
span of bioprosthesis, poor patient compliance) 
• Reduced hospital mortality 
• Reduced morbidity and LOS 
• Improved long term survival 
Thourani et al, Circulation 2003; 108:298-304 
Zaho et al, JTCVS 2007;1257-1263 
Shuhaiber J et al, EJCTS 2007; 31:267-275 
Perrier P et al, Circulation 1984;70:187 
Akins CW, et al. ATS 1994; 58:668-676
 1. create apposition of anterior and posterior 
leaflet in systole. 
 2. increase the valve mobility 
 3. prevent valve stenosis 
 4. reduce the annular dilatation 
 5. remodel the annulus 
 6. remove all the infective foci in case of 
endocarditis.
 Myxomatous mitral valve disease is most 
common indication of mitral valve surgery . 
 90% of the mitral valves are amneble to 
surgical repair. 
 Features of myxomatous mitral valve: 
1. Dilated annulus 
2. Elongated redundant leaflets 
3. Chordae may be thin or thick, ruptured or 
elongated
 Symptomatic patients with mitral valve disease 
and 3+ and 4+ regurgitation. 
 Asymptomatic patients with 3+ or 4+ 
regurgitation and evidence of decreased LV 
function demonstrated by LV dilatation and 
decreased EF and new onset atrial fibrillation.
 Principles of repair includes: 
1. Apposition of anterior and posterior leaflet in 
systole. 
2. Reducing the height of posterior leaflet(most 
critical step). 
3. Stabilizing the AML (by repair or replacement 
of chordae). 
4. Remodelling the annulus by prosthetic ring.
 In case of the myxomatous mitral valve disease 
in around 80% of cases it is the PML which is 
involved (especially p2) and in 20% cases 
pathology involves AML. 
 if we deal with the PML and annulus 
effectively ,AML can be left intact . Repair of 
AML is required in specific situations.
 Quadrangular 
resection 
 Sliding plasty(leaflet 
advancement 
technique) 
 Chordal replacement 
 Anterior leaflet 
commissuroplasty 
 Folding plasty
 This technique is used when posterior leaflet is 
markedly elongated specifically P2 sgment. 
 Here we perform a limited resection of the 
involved segment removing minimal number 
of adjascent chordae and much of the 
supporting structures. This effectively reduce 
the height of PML. 
 The area is excised in trapezoid or 
quadrangular shape with narrowest portion of 
trapezoid at the annulus.
 After resection the remaining parts of the 
leaflet are brought together by suturing the 
leaflet to annulus and to each other directly. 
 First the two annular stitches are brought 
together by running sutures followed by 
approximating the leaflet parts from tip to 
annulus. 
 Disadvantage: 
1. Distortion of annulus if the involved segment is 
large.
 With this technique one incorporates excess 
tissue from remaining segments of posterior 
leaflet, bringing the remaining segments 
together and at same time preserving as many 
chordae . 
 Here after quadrangular resection the incision 
given along the annulus in remaining leaflet 
tissue upto both the commissure followed by 
gradual reattachmentof leaflet to annulus by 
advancing the remaining leaflet in space 
vacated by resected tissue.
 This technique allows remodeling of tissue 
which can be easily adjusted to residual tissue 
and height of leaflet. 
 Pledgeted sutures are not used as they cause 
scarring and provide a site for potential 
thrombus formation. 
 Running sutures along the annulus margin are 
important as they help to reduce the height of 
posterior leaflet. 
 Any annular distortion is taken care by 
annuloplasty ring.
 Placing annuloplasty ring is final step of basic 
mitral valve repair. 
 Most important aspect of ring selection is to 
find exact size and shape . 
 To exactly size the ring there are two methods: 
1. Intertrigonal distance 
2. The height of anterior leaflet.
 To mark the two trigones we first place U 
stitches at the two trigones . These stitches help 
to stabilize the intertrigonal area for exact 
sizing. 
 Rings can be implanted by running sutures but 
most commonly deep intraventricular annular 
mattress sutures are placed. 
 9-11 sutures are usually sufficient to 
completely encircle even the most dilated 
valves.
 For myxomatous mitral valve disease it is 
better to upsize the ring rather than 
downsizing so as to minimizing the possibility 
of development of SAM.
 This technique is used when the commissural 
part of the posterior leaflet is prolapsed . 
 Here we take a suture from diseased segment 
of posterior leaflet and pass it through the 
normal opposite leaflet tissue and tying the 
knot on the surface of leaflet thus obliterating 
the prolapsed segment.
 Chordal replacement 
 Alfieri / E2E 
 Chordal transfer 
 Papillary muscle 
repositioning 
 Triangular resection 
 Flip over technique 
 Durans technique
 Also known as artificial chordal implantation. 
 Technique: 
This technique involves placing a mattress suture 
with a pledget on the papillary muscle to which 
the redundant or ruptured chord has 
beenattached. The two ends of the double-armed 
PTFE are the brought up through the edge of the 
leaflet that needs to be lowered. The critical part of 
this technique is determining the degree to which 
the leaflet is lowered and hence how tightly the 
stitch is tied down.
 Artificial chordae with PTFE is the technique 
that is perhaps the most popular current 
technique for AML pathology. 
 Originally described by Frater and Zussa. 
 Duran has devised a method for more precise 
measurement of the correct height for these 
new chordal structures.
Gillinov, JTCVS 2008 
DISADVANTAGES 
 Difficult sizing 
ADVANTAGES 
 Anatomical 
reconstruction 
 No resection needed
 Also known as alfereri 
technique. 
 First case performed in 
1991 
 Technically simple and 
reproducible
 Indication: 
1. Compromised LV with very less EF. 
2. Ruptured anterior leaflet. 
3. Hemodynamic compromised patient where 
urgent intervention is required . Where we 
cannot prolong the pump time. This procedure 
serves as bailout procedure.
 Technique: it is simple , we approximate 
anterior and posterior leaflets at same level to 
create a figure of 8 mitral valve orifice. 
 Disadvantage: there are chances of mitral valve 
stenosis. To ensure the adequacy of each orifice 
created by the edge-to-edge technique, we also 
measure the diameter of each orifice and 
confirm that it is at least 2 cm in diameter. 
 If the orifices are less than 2 cm in diameter, 
the technique is abandoned.
 When employed to correct the anterior leaflet 
prolapse , a suture affixes the free edge of a 
segment of normal posterior leaflet to free edge 
of prolapsing segment of anterior leaflet. 
 The nomal posterior leaflet with its intact 
chordae serves to anchor the anterior leaflet 
and restricts its motion.
 Also known as chordal shortening and is 
originally described by Carpentier for leaflet 
prolapse due to elongated chordae . 
 The elongated chordae are burried in the trench 
of papillary muscle to effectively reduce the 
size of chordae and thus reducing the prolapse 
of leaflet. 
 Disadvantage: there are high chances of 
recurrence. The scissoring motion of papillary 
muscle causing erosion and rupture.
 One of the first techniques developed by 
Carpentier of chordal shortening involves 
incising the papillary muscle, placing the 
redundant anterior leaflet chords within the 
muscle, and then sewing the papillary muscle 
over the chord, thus entrapping the chordae 
and shortening it.
 In this technique we cut the healthy leaflet 
segment from posterior leaflet with attached 
chordae just opposite to the involved anterior 
leaflet segment and implant this healthy 
segment on diseased leaflet segment. 
 The advantage is that it is not necessary to 
precisely measure the chordal length as natural 
chordae are of adequate length.
 In this technique we excise a oval portion 
from mid and basal part of redundant anterior 
leaflet . All the chordae attached to the 
ventricular surface of the excised part are 
separated and are reapplied to the remaining 
leaflet after the defect in the remaining leaflet is 
approximated by suturing the two parts.
 The technique is similar to the triangular 
resection of PML. 
 To be used when only a small part of the leaflet 
is involved. 
 Annulus distortion can occur if the involved 
area is large.
 Using these techniques upto 90% of 
degenerative mitral valves can be repaired. 
 Hospital mortality is less than 1%. 
 Overall 10 yr freedom from reoperation is 
around 93%. 
 Echocardiographic assessment results in 98% 
10 yr and 97% 20 yr freedom from reoperation. 
 Risk of repair failure is increased by anterior 
leaflet prolapse, chordal shortening and failure 
to use annuloplasty ring.
 Pathology of rheumatic heart disease produces 
varying degrees of regurgitation, stenosis or mixed 
lesions. 
 Acute rheumatic valvulitis produces leaflet 
prolapse and MR. 
 Patients with RHD has components of restricted 
leaflet motion producing stenosis or mixed 
lesions. 
 Restricted leaflet motion is caused by thickening of 
subvalvular apparatus, thickening of leaflets and 
chordae and commissural fusion. There may be 
calcification of valve.
 Symptomatic MS is indication of surgery. 
 A new onset atrial fibrillation 
 A patient with pliable leaflets , no calcification, 
normal chordae can be considered for repair. 
 If the valve is severely distorted , leaflets are 
heavily calcified and there is extreme subvalvar 
fibrosis and shortening the valve should be 
replaced.
 In patients with primary stenosis and limited 
calcification and subvalvar thickening open 
mitral commissurotomy is a good option. 
 Commissurotomy should extend 2mm from 
annulus. More extensive commissurotomy 
causes MR. 
 If MR occurs after commissurotomy 
annuloplasty is done with ring. 
 Patients with combined lesions are best served 
by replacement.
 10 yr freedom from reoperation in patients 
with repaired rheumatic mitral valve is around 
72%. 
 Open mitral commissurotomy provides 78-91% 
10 yr freedom from reoperation. 
 Durability of repair in RHD is limited with as 
many as 50 % developing MR in 5 yrs.
 All the principles of repair are similar except 
that all the infected material must be removed 
and placement of any prosthetic material 
should be avoided. 
 There are 2 challenges: 
1. Removing all infection and leaving sufficient 
tissue for repair of valve. 
2. Remodeling the annulus with autologus 
material without implanting the prosthetic 
ring.
 Pathologic findings include: 
1. Chordal rupture(70%) 
2. Vegetations (62%) 
3. Leaflet perforation (53%) 
4. Abscess (7%)
1. Heart failure nonresponsive to medical 
therapy 
2. Multiple embolic events 
3. Uncontrolled sepsis 
4. Extension of infection to surrounding 
structures 
5. Early operation is indicated for fungal and 
staphylococcal infections.
 Includes: 
1. Preservation of native , living valve apparatus 
which is resistant to infection and concomitant 
avoidance of prosthetic material.
 All the infected material is removed from 
leaflet . Leaflets are completely detached from 
the annulus and the annulus is debrided if 
endocarditis involve the annulus and are 
covered with pericardial lining before 
reattaching the leaflets. 
 Local treatment with iodine solution is 
recommended.
 In case of ruptured chordae to posterior leaflet 
quadrangular resection is performed. 
 Anterior chordal rupture is repaired with 
standard techniques. 
 Anterior leaflet perforation are repaired with 
autologus pericardial patch. 
 Abscess cavities are debrided and excluded 
with pericardial patch. 
 Pericardial annuloplasty is done with both 
active and chronic endocarditis.
 Around 80% of mitral valves with endocarditis 
are amnable to repair. 
 Hospital mortality is around 1-7%. 
 Recurrent endocarditis is rare after mitral valve 
repair. 
 When compared with replacement ,repair of 
infected mitral valve results in greater freedom 
from recurrent infection and higher early and 
late survival.
 1. clefts in posterior leaflet 
 2. with annular calcifications 
 3. systolic anterior motion 
 4. Repair of ischemic MR.
 Clefts when present in posterior leaflet gets 
accentuated after the repair 
 Treatment is approximation of clefts using the 
mattress suture by prolene 4-0.
 Seen mostly in elderly patients and in patients 
with long standing disease. 
 There are two sinarios: 
a) If annulus is not affected by calcification and 
calcification is only subannular: only partial 
resection of calcification is required. 
b) When there is extreme calcification of annular 
and subannular tissue: separate atria from 
ventricle and enblock resection of calcium is 
done followed by reapproximation of atria and 
ventricle
 SAM occurs due use of rigid annuloplasty 
rings and when the height of the PML is 
inadequately reduced for repair. 
 In both of the situations the redundant PML 
pushes the AML towards the septum in systole 
and it results in approximation of AML to 
septum which is enhanced in mid and late 
systole due to venturi effect leading to LVOTO.
 SAM occurs in about 5-10 % cases of repair. 
 In patients at risk SAM is potentiated by 
hypovolemia, vasodiatation and use of 
inotropes. 
 More events of SAM are seen after 
quadrangular resection and is minimised by 
use of sliding plasty.
 Treatment of SAM: 
1. Reresect the PML to reduce the height. 
2. Upsize the annuloplasty ring.
 Mechanism of development of MR can be 
derived from Carpentier’s functional 
classification. 
 According to it ischemic MR can result from 
type I, II, IIIB dysfunctions. 
 Carpentier’s IIIB dysfunction is most 
common and significant form of ischemic MR.
« Surgeons are not basically concerned with lesions. We care more about 
function. Therefore one may define the aim of a valve reconstuction as 
restoring normal leaflet function rather than normal valve anatomy » 
A. Carpentier, the French Correction 1984
 Development of type IIIB dysfunction results 
due to : 
1. Changes in ventricular wall: RWMA, 
increased sphericity 
2. Subvalvar changes includes fibrosis and 
rupture of papillary muscles, teethering of 
papillary muscles, apical and posterolateral 
displcement of papillary muscle leading to 
restriction of leaflet motion. 
3. Annular dilatation and distortion due to 
alteration in geometry of post infarction LV.
 Mechanism can be divided into 3 catagories. 
1. Ruptured papillary muscles 
2. Infarcted but unruptured papillary muscle 
lads to fibrosis and chordal elongation. 
3. Functional MR: 
a. Left ventricular dysfunction and dilatation 
b. Annular dilatation 
c. Both LV dilatation and annular dilatation.
1. Severe ischemic MR 
2. Mild to moderate ischemic MR: Controversial 
A patient with ischemic MR of grade 2+ onwards 
require mitral valve repair concomitant with 
revascularization.
1. Median sternotomy is surgical approach of 
choice. 
2. Right lateral thoracotomy may be used in 
patients with prior CABG and functioning 
grafts. Here we perform right anterolateral 
thoracotomy through 4th ICS. 
3. Right thoracotomy is C/I inpatients with 
previous right thoracic surgeries, COPD, 
severe AR.
 Mitral valve repair is standard treatment for 
ischemic mitral regurgitation. 
 Here the anterior paracommissural scallop (P1 
) constitutes the referance point. 
 Mitral annulus is then examined to access the 
dilatation. 
 It is the P2 & P3 segments of posterior leaflet 
which are most commonly involved as they are 
attached to posterior papillary muscle which 
has single blood supply.
 Remodeling annuloplasty using undersized 
ring is the technique of choice in type IIIB 
dysfunction. 
 Most commonly braided 2-0 sutures are used 
to implant the ring. 
 The anterior commissure is the most difficult 
area to expose for suture placement and is 
generally approached last. 
 Downsizing the physio ring by 1 or 2 sizes or 
to use a true sized Mc Carthy-Carpentier IMR 
Etlogix ring is used for annuloplasty.
 This IMR ring asymmetrically downsize the 
annulus .this ring downsizes the D3 dimension 
by 2 sizes and D2 dimension by 1 size. This 
makes it possible to select true size ring. 
Further more this ring contains titanium core 
which allows complete fixation of septolateral 
dimension during entire cardiac cycle.
 Papillary muscle rupture is managed by mitral 
valve replacement with bioprosthesis. 
 Papillary muscle infarction without rupture is 
managed with repair techniques described 
with degenerative mitral valve disease and 
prolapse. 
 If the portion of posterior leaflet is affected 
quadrangular resection is indicated. 
 If there is anterior leaflet prolapse , chordal 
transfer and chordal replacement suffice.
 Hospital mortality after valve repair in 
ischemic MR is around 3-6%. 
 5 yr survival is around 58%. 
 Patients with ruptured papillary muscle have 
best long term survival , likely due to better 
preservation of LV function. 
 Patients with ischemic MR have more damaged 
LV and correspondingly a reduced longevity. 
 Because the long term survival is limited the 
durability of mitral valve repair in patients 
with ischemic MR is difficult to establish.
 Rings can be: 
1. Rigid / flexible/ semiflexible 
2. Complete/ incomplete/ asymmetric ring 
Complete ring Incomplete ring 
1. CE physio ring(titanium + velor 
decron) 
2. Medtronic complete flexible 
ring(titanium core with silicon felt, 3 
marks for referance.) 
3. St jude semiflexible ring (AP 
angulation) 
4. Carbomedics complete flexible ring 
1.CE ring made of titanium core. 
2. Cogrove C shaped ring. 
3. Homemade ring with stainless steel 
wire.
 Choice of ring: 
1. Degenerative diseases: rigid or flexible ring. 
2. RHD/ endocarditis/ congenital mitral disease: 
rigid ring. 
3. Ischemic MR : rigid ring or asymmetric 
ring(IMR ring by CE) 
4. Functional MR: geoform ring 
5. If underlying myocardium is severely diseased 
the choice is rigid ring and if only valve tissue 
is involved then incomplete ring is choice.
 Rigid rings: there occur no change in diameter 
of ring in different parts of cardiac cycle. They 
may interfere with LV filling and functioning, 
LVOTO. 
 Incomplete rings: they are used when only 
annulus is dilated. No support to anterior part 
of valve . 
 Semiflexible rings: here the anterior portion is 
rigid, so no change occurs in transverse 
diameter. Posterior part is flexible so allows 
change in transverse diameter of valve.
1. Retain the shape and size of annulus. 
2. Keeps tension off the suture lines 
3. Increases leaflet coaptation 
4. Prevents recurrent dilatation of annulus.
 Hospital mortality for 
isolated first time 
elective MV repair is 
2.5% (males) to 3.9% 
(females) 
 Operative risk is higher 
in elderly pts, 
associated CABG, 
NYHA III-IV, low EF 
and reoperation 
100% 
90% 
80% 
70% 
60% 
50% 
40% 
30% 
20% 
10% 
0% 
1991 
1992 
1993 
1994 
1995 
1996 
1997 
1998 
1999 
2000 
Replacement Repair 
Savage EB, et al Ann Thorac Surg 2003;75:820–5
 Older age is associated 
to 
 Higher mortality 
 Higher morbidity 
 Longer LOS 
 2/3 of pts older than 70 
years are denied surgery 
(Euroheart Survey) 
Mehta et al. Ann Thorac Surg 2002;74:1459-67
Braunberger, et al Circulation. 2001;104[suppl I]:I-8-I-11.
Years 
100 
Survival (%) 
80 
60 
40 
20 
72% 
Ejection Fraction 
EF  60% 
EF 50-60% 
53% 
EF < 50% 32% 
P = 0.0001 
0 
0 2 4 6 8 10 
Enriquez-Sarano M et al. Circulation 1994; 90: 830 - 37
• If mitral repair is performed before the onset of 
severe symptoms (congestive heart failure, 
arrhythmias), life expectancy is restored 
David T et al, J Thorac Cardiovasc Surg 2003;125:1143-52
1072 patients with degenerative mitral regurgitation 
operated upon at CCF between 1985 and 1997 
Gillinov et alJ Thorac Cardiovasc Surg 1998;116:734-43
Flameng W, et al. Circulation. 2003;107:1609-1613
 Thank you

More Related Content

What's hot

segment approach to congenital heart diseases
segment approach to congenital heart diseasessegment approach to congenital heart diseases
segment approach to congenital heart diseases
Sumiya Arshad
 
Mitral valve anatomy
Mitral valve anatomyMitral valve anatomy
Mitral valve anatomy
DR NIKUNJ SHEKHADA
 
BALLOON AORTIC VALVULOPLASTY
BALLOON AORTIC VALVULOPLASTYBALLOON AORTIC VALVULOPLASTY
BALLOON AORTIC VALVULOPLASTY
Praveen Nagula
 
Lvad
LvadLvad
Mitral valve repair//TRANSCATHETER MITRAL VALVE REPAIR/ TRANSCATHETER MITRAL ...
Mitral valve repair//TRANSCATHETER MITRAL VALVE REPAIR/ TRANSCATHETER MITRAL ...Mitral valve repair//TRANSCATHETER MITRAL VALVE REPAIR/ TRANSCATHETER MITRAL ...
Mitral valve repair//TRANSCATHETER MITRAL VALVE REPAIR/ TRANSCATHETER MITRAL ...
Dr Virbhan Balai
 
Homografts in cardiac surgery
Homografts in cardiac surgeryHomografts in cardiac surgery
Homografts in cardiac surgery
India CTVS
 
Aortic valve repair
Aortic valve repairAortic valve repair
Aortic valve repair
maxrox99
 
Left ventricular aneurysm
Left ventricular aneurysmLeft ventricular aneurysm
Left ventricular aneurysm
Ramachandra Barik
 
Diastolic Dysfunction 2016
Diastolic Dysfunction 2016Diastolic Dysfunction 2016
Diastolic Dysfunction 2016
drabhishekbabbu
 
Revisiting bentall procedure
Revisiting bentall procedureRevisiting bentall procedure
Revisiting bentall procedure
Dicky A Wartono
 
Mitral valve anatomy - ppt by kunwar sidharth
Mitral valve    anatomy - ppt by kunwar sidharthMitral valve    anatomy - ppt by kunwar sidharth
Mitral valve anatomy - ppt by kunwar sidharth
kunwar sidharth
 
Tavi,Transcatheter Aortic Valve Replacement, TAVI,TAVR,
Tavi,Transcatheter Aortic Valve Replacement, TAVI,TAVR,Tavi,Transcatheter Aortic Valve Replacement, TAVI,TAVR,
Tavi,Transcatheter Aortic Valve Replacement, TAVI,TAVR,
Dr.Hasan Mahmud
 
ROSS PROCEDURE
ROSS PROCEDUREROSS PROCEDURE
ROSS PROCEDURE
Manu Jacob
 
Temporary Pacemaker Slides
Temporary Pacemaker SlidesTemporary Pacemaker Slides
Temporary Pacemaker Slidesmaltiaziz24
 
Temporary cardiac pacing
Temporary cardiac pacingTemporary cardiac pacing
Temporary cardiac pacing
Mashiul Alam
 
Aortic SURGERY Intro
Aortic SURGERY IntroAortic SURGERY Intro
Aortic SURGERY Intro
Dicky A Wartono
 
Av canal defect
Av canal defectAv canal defect
Av canal defect
drsrb
 
Transesophageal echocardiography(TEE)
Transesophageal echocardiography(TEE)Transesophageal echocardiography(TEE)
Transesophageal echocardiography(TEE)
LPS Institute of Cardiology Kanpur UP India
 
Ventricular Assist Device
Ventricular Assist DeviceVentricular Assist Device
Ventricular Assist DeviceNikki Ann Testa
 

What's hot (20)

IABP
IABPIABP
IABP
 
segment approach to congenital heart diseases
segment approach to congenital heart diseasessegment approach to congenital heart diseases
segment approach to congenital heart diseases
 
Mitral valve anatomy
Mitral valve anatomyMitral valve anatomy
Mitral valve anatomy
 
BALLOON AORTIC VALVULOPLASTY
BALLOON AORTIC VALVULOPLASTYBALLOON AORTIC VALVULOPLASTY
BALLOON AORTIC VALVULOPLASTY
 
Lvad
LvadLvad
Lvad
 
Mitral valve repair//TRANSCATHETER MITRAL VALVE REPAIR/ TRANSCATHETER MITRAL ...
Mitral valve repair//TRANSCATHETER MITRAL VALVE REPAIR/ TRANSCATHETER MITRAL ...Mitral valve repair//TRANSCATHETER MITRAL VALVE REPAIR/ TRANSCATHETER MITRAL ...
Mitral valve repair//TRANSCATHETER MITRAL VALVE REPAIR/ TRANSCATHETER MITRAL ...
 
Homografts in cardiac surgery
Homografts in cardiac surgeryHomografts in cardiac surgery
Homografts in cardiac surgery
 
Aortic valve repair
Aortic valve repairAortic valve repair
Aortic valve repair
 
Left ventricular aneurysm
Left ventricular aneurysmLeft ventricular aneurysm
Left ventricular aneurysm
 
Diastolic Dysfunction 2016
Diastolic Dysfunction 2016Diastolic Dysfunction 2016
Diastolic Dysfunction 2016
 
Revisiting bentall procedure
Revisiting bentall procedureRevisiting bentall procedure
Revisiting bentall procedure
 
Mitral valve anatomy - ppt by kunwar sidharth
Mitral valve    anatomy - ppt by kunwar sidharthMitral valve    anatomy - ppt by kunwar sidharth
Mitral valve anatomy - ppt by kunwar sidharth
 
Tavi,Transcatheter Aortic Valve Replacement, TAVI,TAVR,
Tavi,Transcatheter Aortic Valve Replacement, TAVI,TAVR,Tavi,Transcatheter Aortic Valve Replacement, TAVI,TAVR,
Tavi,Transcatheter Aortic Valve Replacement, TAVI,TAVR,
 
ROSS PROCEDURE
ROSS PROCEDUREROSS PROCEDURE
ROSS PROCEDURE
 
Temporary Pacemaker Slides
Temporary Pacemaker SlidesTemporary Pacemaker Slides
Temporary Pacemaker Slides
 
Temporary cardiac pacing
Temporary cardiac pacingTemporary cardiac pacing
Temporary cardiac pacing
 
Aortic SURGERY Intro
Aortic SURGERY IntroAortic SURGERY Intro
Aortic SURGERY Intro
 
Av canal defect
Av canal defectAv canal defect
Av canal defect
 
Transesophageal echocardiography(TEE)
Transesophageal echocardiography(TEE)Transesophageal echocardiography(TEE)
Transesophageal echocardiography(TEE)
 
Ventricular Assist Device
Ventricular Assist DeviceVentricular Assist Device
Ventricular Assist Device
 

Similar to Mitral valve repair and related aspects

Percutaneous mitral valve interventions for MR
Percutaneous mitral valve interventions for MRPercutaneous mitral valve interventions for MR
Percutaneous mitral valve interventions for MR
Yogesh Shilimkar
 
Mitra clip
Mitra clipMitra clip
Mitra clip
Dr Virbhan Balai
 
Aortic Root SUrgery
Aortic Root SUrgeryAortic Root SUrgery
Aortic Root SUrgery
Dicky A Wartono
 
Percutaneous Transcatheter Mitral Valve Replacement
Percutaneous Transcatheter Mitral Valve ReplacementPercutaneous Transcatheter Mitral Valve Replacement
Percutaneous Transcatheter Mitral Valve Replacement
Shadab Ahmad
 
Transcatheter therapy for mitral regurgitation
Transcatheter therapy for mitral regurgitationTranscatheter therapy for mitral regurgitation
Transcatheter therapy for mitral regurgitation
SR,CARDIOLOGY,JIPMER,PUDUCHERRY
 
Chordal preservation DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
Chordal preservation DR  NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)Chordal preservation DR  NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
Chordal preservation DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
DR NIKUNJ SHEKHADA
 
Successful Valve in Ring Abolishing the Stenosis and Regurgitation with Robus...
Successful Valve in Ring Abolishing the Stenosis and Regurgitation with Robus...Successful Valve in Ring Abolishing the Stenosis and Regurgitation with Robus...
Successful Valve in Ring Abolishing the Stenosis and Regurgitation with Robus...
Premier Publishers
 
Chordal preservation in mitral valve replacement
Chordal preservation in  mitral valve replacementChordal preservation in  mitral valve replacement
Chordal preservation in mitral valve replacement
Drvasanthi
 
Aortic Valve Sparring Root Replacement David vs yacoub
Aortic Valve Sparring Root Replacement David vs yacoubAortic Valve Sparring Root Replacement David vs yacoub
Aortic Valve Sparring Root Replacement David vs yacoub
Dicky A Wartono
 
Aortic Valve Sparring Root Replacement
Aortic Valve Sparring Root ReplacementAortic Valve Sparring Root Replacement
Aortic Valve Sparring Root Replacement
Dicky A Wartono
 
Transcatheter therapy for Mitral Regurgitation (MR)
Transcatheter therapy for Mitral Regurgitation (MR)Transcatheter therapy for Mitral Regurgitation (MR)
Transcatheter therapy for Mitral Regurgitation (MR)
Raghu Kishore Galla
 
Mitral valve repair in rheumatic patients
Mitral valve repair in rheumatic patientsMitral valve repair in rheumatic patients
Mitral valve repair in rheumatic patients
escts2012
 
Video assisted thoracic surgery (vats)
Video assisted thoracic surgery (vats)Video assisted thoracic surgery (vats)
Video assisted thoracic surgery (vats)
Vijay Verma
 
Splenic Salvage .pptx
Splenic Salvage .pptxSplenic Salvage .pptx
Splenic Salvage .pptx
SherifAli90
 
tracheal stenosis Dr.muthukumar dr.semmanaselvan
tracheal stenosis Dr.muthukumar dr.semmanaselvan tracheal stenosis Dr.muthukumar dr.semmanaselvan
tracheal stenosis Dr.muthukumar dr.semmanaselvan
gopal25k
 
9 autogenous temporomandibular joint replacement
9 autogenous temporomandibular joint replacement9 autogenous temporomandibular joint replacement
9 autogenous temporomandibular joint replacement
DrKamini Dadsena
 
valve replacement and reconstruction.pptx
valve replacement and reconstruction.pptxvalve replacement and reconstruction.pptx
valve replacement and reconstruction.pptx
EDWINjose43
 
Radial artery pseudoaneurysm
Radial artery pseudoaneurysmRadial artery pseudoaneurysm
Radial artery pseudoaneurysm
Ramachandra Barik
 
Percutaneous treatment of communited patellar fracture.pptx
Percutaneous treatment of communited patellar fracture.pptxPercutaneous treatment of communited patellar fracture.pptx
Percutaneous treatment of communited patellar fracture.pptx
AyalewKomande1
 

Similar to Mitral valve repair and related aspects (20)

Percutaneous mitral valve interventions for MR
Percutaneous mitral valve interventions for MRPercutaneous mitral valve interventions for MR
Percutaneous mitral valve interventions for MR
 
Mitra clip
Mitra clipMitra clip
Mitra clip
 
Aortic Root SUrgery
Aortic Root SUrgeryAortic Root SUrgery
Aortic Root SUrgery
 
Percutaneous Transcatheter Mitral Valve Replacement
Percutaneous Transcatheter Mitral Valve ReplacementPercutaneous Transcatheter Mitral Valve Replacement
Percutaneous Transcatheter Mitral Valve Replacement
 
Transcatheter therapy for mitral regurgitation
Transcatheter therapy for mitral regurgitationTranscatheter therapy for mitral regurgitation
Transcatheter therapy for mitral regurgitation
 
Chordal preservation DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
Chordal preservation DR  NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)Chordal preservation DR  NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
Chordal preservation DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
 
Successful Valve in Ring Abolishing the Stenosis and Regurgitation with Robus...
Successful Valve in Ring Abolishing the Stenosis and Regurgitation with Robus...Successful Valve in Ring Abolishing the Stenosis and Regurgitation with Robus...
Successful Valve in Ring Abolishing the Stenosis and Regurgitation with Robus...
 
Chordal preservation in mitral valve replacement
Chordal preservation in  mitral valve replacementChordal preservation in  mitral valve replacement
Chordal preservation in mitral valve replacement
 
Aortic Valve Sparring Root Replacement David vs yacoub
Aortic Valve Sparring Root Replacement David vs yacoubAortic Valve Sparring Root Replacement David vs yacoub
Aortic Valve Sparring Root Replacement David vs yacoub
 
David vs yacoubf
David vs yacoubfDavid vs yacoubf
David vs yacoubf
 
Aortic Valve Sparring Root Replacement
Aortic Valve Sparring Root ReplacementAortic Valve Sparring Root Replacement
Aortic Valve Sparring Root Replacement
 
Transcatheter therapy for Mitral Regurgitation (MR)
Transcatheter therapy for Mitral Regurgitation (MR)Transcatheter therapy for Mitral Regurgitation (MR)
Transcatheter therapy for Mitral Regurgitation (MR)
 
Mitral valve repair in rheumatic patients
Mitral valve repair in rheumatic patientsMitral valve repair in rheumatic patients
Mitral valve repair in rheumatic patients
 
Video assisted thoracic surgery (vats)
Video assisted thoracic surgery (vats)Video assisted thoracic surgery (vats)
Video assisted thoracic surgery (vats)
 
Splenic Salvage .pptx
Splenic Salvage .pptxSplenic Salvage .pptx
Splenic Salvage .pptx
 
tracheal stenosis Dr.muthukumar dr.semmanaselvan
tracheal stenosis Dr.muthukumar dr.semmanaselvan tracheal stenosis Dr.muthukumar dr.semmanaselvan
tracheal stenosis Dr.muthukumar dr.semmanaselvan
 
9 autogenous temporomandibular joint replacement
9 autogenous temporomandibular joint replacement9 autogenous temporomandibular joint replacement
9 autogenous temporomandibular joint replacement
 
valve replacement and reconstruction.pptx
valve replacement and reconstruction.pptxvalve replacement and reconstruction.pptx
valve replacement and reconstruction.pptx
 
Radial artery pseudoaneurysm
Radial artery pseudoaneurysmRadial artery pseudoaneurysm
Radial artery pseudoaneurysm
 
Percutaneous treatment of communited patellar fracture.pptx
Percutaneous treatment of communited patellar fracture.pptxPercutaneous treatment of communited patellar fracture.pptx
Percutaneous treatment of communited patellar fracture.pptx
 

Recently uploaded

heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Dr KHALID B.M
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
Catherine Liao
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 

Recently uploaded (20)

heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...The hemodynamic and autonomic determinants of elevated blood pressure in obes...
The hemodynamic and autonomic determinants of elevated blood pressure in obes...
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 

Mitral valve repair and related aspects

  • 1. Dr Dheeraj sharma M.Ch (CTVS) Resident
  • 2.  Sir Thomas Lauder Brunton, a Scottish physician, first introduced the concept of surgical repair of the mitral valve in 1902.  Elliot Cutler ,Professor of Surgery at the Peter Bent Brigham Hospital in Boston, performed the world’s first successful mitral valve operation in 1923 by carrying out a transventricular commissurotomy with a neurosurgical tenotomy knife.  Henry Souttar of England performed a single successful transatrial finger commissurotomy in 1925.  Surgical treatment of mitral regurgitation for prolapse was first introduced in the 1950s.
  • 3.  Harold and kay obliterated the commisures using sequence of mattress sutures.  Paneth and devega did the annuloplasty by taking the circumferential sutures around the annulus.  In 1960 McGoon proposed the resection of part of leaflets with ruptured chordae as a part of repair.  Carpentier and Duran started the use of prosthetic rings to remodel the mitral valve annulus.
  • 4.
  • 5.
  • 6. Organic • Degenerative • Barlow’s • Dystrophic • Marfan’s • Other • Endocarditis • Rheumatic • Post-traumatic Functional • Ischemic • DCM
  • 7. RECOMMENDATION COR LOE MV surgery is recommended for symptomatic patients with I B chronic severe primary MR (stage D) and LVEF >30% MV surgery is recommended for asymptomatic patients with chronic severe primary MR and LV dysfunction (LVEF 30%– 60% and/or LVESD ≥40 mm, stage C2) I B MV repair is recommended in preference to MVR when surgical treatment is indicated for patients with chronic severe primary MR limited to the posterior leaflet I B MV repair is recommended in preference to MVR when surgical treatment is indicated for patients with chronic severe primary MR involving the anterior leaflet or both leaflets when a successful and durable repair can be accomplished I B Concomitant MV repair or replacement is indicated in patients with chronic severe primary MR undergoing cardiac surgery for other indications . I B
  • 8. MV repair is reasonable in asymptomatic patients with chronic severe primary MR (stage C1) with preserved LV function (LVEF >60% and LVESD <40 mm) in whom the likelihood of a successful and durable repair without residual MR is >95% with an expected mortality rate of <1% when performed at a Heart Valve Center of Excellence IIA B MV repair is reasonable for asymptomatic patients with chronic severe nonrheumatic primary MR (stage C1) and preserved LV function in whom there is a high likelihood of a successful and durable repair with 1) new onset of AF or 2) resting pulmonary hypertension (PA systolic arterial pressure >50 mm Hg) IIA B Concomitant MV repair is reasonable in patients with chronic moderate primary MR (stage B) undergoing cardiac surgery for other indications IIA C MV surgery may be considered in symptomatic patients with chronic severe primary MR and LVEF 30% (stage D) IIB C MV repair may be considered in patients with rheumatic mitral valve disease when surgical treatment is indicated if a durable and successful repair is likely or if the reliability of long-term anticoagulation management is questionable IIB B Transcatheter MV repair may be considered for severely symptomatic patients (NYHA class III/IV) with chronic severe primary MR (stage D) who have a reasonable life expectancy but a prohibitive surgical risk because of severe comorbidities IIB B MVR should not be performed for treatment of isolated severe primary MR limited to less than one half of the posterior leaflet unless MV repair has been attempted and was unsuccessful III B
  • 9.
  • 10.
  • 11.  1. mitral valve replacement.  2. mitral valve repair
  • 12. • Better preservation of LV function • Avoidance of prosthesis related events(hazards of anticoagulation, stroke, endocarditis, short life span of bioprosthesis, poor patient compliance) • Reduced hospital mortality • Reduced morbidity and LOS • Improved long term survival Thourani et al, Circulation 2003; 108:298-304 Zaho et al, JTCVS 2007;1257-1263 Shuhaiber J et al, EJCTS 2007; 31:267-275 Perrier P et al, Circulation 1984;70:187 Akins CW, et al. ATS 1994; 58:668-676
  • 13.  1. create apposition of anterior and posterior leaflet in systole.  2. increase the valve mobility  3. prevent valve stenosis  4. reduce the annular dilatation  5. remodel the annulus  6. remove all the infective foci in case of endocarditis.
  • 14.  Myxomatous mitral valve disease is most common indication of mitral valve surgery .  90% of the mitral valves are amneble to surgical repair.  Features of myxomatous mitral valve: 1. Dilated annulus 2. Elongated redundant leaflets 3. Chordae may be thin or thick, ruptured or elongated
  • 15.  Symptomatic patients with mitral valve disease and 3+ and 4+ regurgitation.  Asymptomatic patients with 3+ or 4+ regurgitation and evidence of decreased LV function demonstrated by LV dilatation and decreased EF and new onset atrial fibrillation.
  • 16.  Principles of repair includes: 1. Apposition of anterior and posterior leaflet in systole. 2. Reducing the height of posterior leaflet(most critical step). 3. Stabilizing the AML (by repair or replacement of chordae). 4. Remodelling the annulus by prosthetic ring.
  • 17.  In case of the myxomatous mitral valve disease in around 80% of cases it is the PML which is involved (especially p2) and in 20% cases pathology involves AML.  if we deal with the PML and annulus effectively ,AML can be left intact . Repair of AML is required in specific situations.
  • 18.  Quadrangular resection  Sliding plasty(leaflet advancement technique)  Chordal replacement  Anterior leaflet commissuroplasty  Folding plasty
  • 19.  This technique is used when posterior leaflet is markedly elongated specifically P2 sgment.  Here we perform a limited resection of the involved segment removing minimal number of adjascent chordae and much of the supporting structures. This effectively reduce the height of PML.  The area is excised in trapezoid or quadrangular shape with narrowest portion of trapezoid at the annulus.
  • 20.  After resection the remaining parts of the leaflet are brought together by suturing the leaflet to annulus and to each other directly.  First the two annular stitches are brought together by running sutures followed by approximating the leaflet parts from tip to annulus.  Disadvantage: 1. Distortion of annulus if the involved segment is large.
  • 21.
  • 22.  With this technique one incorporates excess tissue from remaining segments of posterior leaflet, bringing the remaining segments together and at same time preserving as many chordae .  Here after quadrangular resection the incision given along the annulus in remaining leaflet tissue upto both the commissure followed by gradual reattachmentof leaflet to annulus by advancing the remaining leaflet in space vacated by resected tissue.
  • 23.  This technique allows remodeling of tissue which can be easily adjusted to residual tissue and height of leaflet.  Pledgeted sutures are not used as they cause scarring and provide a site for potential thrombus formation.  Running sutures along the annulus margin are important as they help to reduce the height of posterior leaflet.  Any annular distortion is taken care by annuloplasty ring.
  • 24.  Placing annuloplasty ring is final step of basic mitral valve repair.  Most important aspect of ring selection is to find exact size and shape .  To exactly size the ring there are two methods: 1. Intertrigonal distance 2. The height of anterior leaflet.
  • 25.
  • 26.  To mark the two trigones we first place U stitches at the two trigones . These stitches help to stabilize the intertrigonal area for exact sizing.  Rings can be implanted by running sutures but most commonly deep intraventricular annular mattress sutures are placed.  9-11 sutures are usually sufficient to completely encircle even the most dilated valves.
  • 27.  For myxomatous mitral valve disease it is better to upsize the ring rather than downsizing so as to minimizing the possibility of development of SAM.
  • 28.
  • 29.
  • 30.  This technique is used when the commissural part of the posterior leaflet is prolapsed .  Here we take a suture from diseased segment of posterior leaflet and pass it through the normal opposite leaflet tissue and tying the knot on the surface of leaflet thus obliterating the prolapsed segment.
  • 31.
  • 32.
  • 33.  Chordal replacement  Alfieri / E2E  Chordal transfer  Papillary muscle repositioning  Triangular resection  Flip over technique  Durans technique
  • 34.  Also known as artificial chordal implantation.  Technique: This technique involves placing a mattress suture with a pledget on the papillary muscle to which the redundant or ruptured chord has beenattached. The two ends of the double-armed PTFE are the brought up through the edge of the leaflet that needs to be lowered. The critical part of this technique is determining the degree to which the leaflet is lowered and hence how tightly the stitch is tied down.
  • 35.  Artificial chordae with PTFE is the technique that is perhaps the most popular current technique for AML pathology.  Originally described by Frater and Zussa.  Duran has devised a method for more precise measurement of the correct height for these new chordal structures.
  • 36.
  • 37. Gillinov, JTCVS 2008 DISADVANTAGES  Difficult sizing ADVANTAGES  Anatomical reconstruction  No resection needed
  • 38.  Also known as alfereri technique.  First case performed in 1991  Technically simple and reproducible
  • 39.  Indication: 1. Compromised LV with very less EF. 2. Ruptured anterior leaflet. 3. Hemodynamic compromised patient where urgent intervention is required . Where we cannot prolong the pump time. This procedure serves as bailout procedure.
  • 40.  Technique: it is simple , we approximate anterior and posterior leaflets at same level to create a figure of 8 mitral valve orifice.  Disadvantage: there are chances of mitral valve stenosis. To ensure the adequacy of each orifice created by the edge-to-edge technique, we also measure the diameter of each orifice and confirm that it is at least 2 cm in diameter.  If the orifices are less than 2 cm in diameter, the technique is abandoned.
  • 41.
  • 42.  When employed to correct the anterior leaflet prolapse , a suture affixes the free edge of a segment of normal posterior leaflet to free edge of prolapsing segment of anterior leaflet.  The nomal posterior leaflet with its intact chordae serves to anchor the anterior leaflet and restricts its motion.
  • 43.  Also known as chordal shortening and is originally described by Carpentier for leaflet prolapse due to elongated chordae .  The elongated chordae are burried in the trench of papillary muscle to effectively reduce the size of chordae and thus reducing the prolapse of leaflet.  Disadvantage: there are high chances of recurrence. The scissoring motion of papillary muscle causing erosion and rupture.
  • 44.  One of the first techniques developed by Carpentier of chordal shortening involves incising the papillary muscle, placing the redundant anterior leaflet chords within the muscle, and then sewing the papillary muscle over the chord, thus entrapping the chordae and shortening it.
  • 45.
  • 46.  In this technique we cut the healthy leaflet segment from posterior leaflet with attached chordae just opposite to the involved anterior leaflet segment and implant this healthy segment on diseased leaflet segment.  The advantage is that it is not necessary to precisely measure the chordal length as natural chordae are of adequate length.
  • 47.
  • 48.  In this technique we excise a oval portion from mid and basal part of redundant anterior leaflet . All the chordae attached to the ventricular surface of the excised part are separated and are reapplied to the remaining leaflet after the defect in the remaining leaflet is approximated by suturing the two parts.
  • 49.
  • 50.  The technique is similar to the triangular resection of PML.  To be used when only a small part of the leaflet is involved.  Annulus distortion can occur if the involved area is large.
  • 51.
  • 52.  Using these techniques upto 90% of degenerative mitral valves can be repaired.  Hospital mortality is less than 1%.  Overall 10 yr freedom from reoperation is around 93%.  Echocardiographic assessment results in 98% 10 yr and 97% 20 yr freedom from reoperation.  Risk of repair failure is increased by anterior leaflet prolapse, chordal shortening and failure to use annuloplasty ring.
  • 53.  Pathology of rheumatic heart disease produces varying degrees of regurgitation, stenosis or mixed lesions.  Acute rheumatic valvulitis produces leaflet prolapse and MR.  Patients with RHD has components of restricted leaflet motion producing stenosis or mixed lesions.  Restricted leaflet motion is caused by thickening of subvalvular apparatus, thickening of leaflets and chordae and commissural fusion. There may be calcification of valve.
  • 54.  Symptomatic MS is indication of surgery.  A new onset atrial fibrillation  A patient with pliable leaflets , no calcification, normal chordae can be considered for repair.  If the valve is severely distorted , leaflets are heavily calcified and there is extreme subvalvar fibrosis and shortening the valve should be replaced.
  • 55.  In patients with primary stenosis and limited calcification and subvalvar thickening open mitral commissurotomy is a good option.  Commissurotomy should extend 2mm from annulus. More extensive commissurotomy causes MR.  If MR occurs after commissurotomy annuloplasty is done with ring.  Patients with combined lesions are best served by replacement.
  • 56.
  • 57.  10 yr freedom from reoperation in patients with repaired rheumatic mitral valve is around 72%.  Open mitral commissurotomy provides 78-91% 10 yr freedom from reoperation.  Durability of repair in RHD is limited with as many as 50 % developing MR in 5 yrs.
  • 58.  All the principles of repair are similar except that all the infected material must be removed and placement of any prosthetic material should be avoided.  There are 2 challenges: 1. Removing all infection and leaving sufficient tissue for repair of valve. 2. Remodeling the annulus with autologus material without implanting the prosthetic ring.
  • 59.  Pathologic findings include: 1. Chordal rupture(70%) 2. Vegetations (62%) 3. Leaflet perforation (53%) 4. Abscess (7%)
  • 60. 1. Heart failure nonresponsive to medical therapy 2. Multiple embolic events 3. Uncontrolled sepsis 4. Extension of infection to surrounding structures 5. Early operation is indicated for fungal and staphylococcal infections.
  • 61.  Includes: 1. Preservation of native , living valve apparatus which is resistant to infection and concomitant avoidance of prosthetic material.
  • 62.  All the infected material is removed from leaflet . Leaflets are completely detached from the annulus and the annulus is debrided if endocarditis involve the annulus and are covered with pericardial lining before reattaching the leaflets.  Local treatment with iodine solution is recommended.
  • 63.  In case of ruptured chordae to posterior leaflet quadrangular resection is performed.  Anterior chordal rupture is repaired with standard techniques.  Anterior leaflet perforation are repaired with autologus pericardial patch.  Abscess cavities are debrided and excluded with pericardial patch.  Pericardial annuloplasty is done with both active and chronic endocarditis.
  • 64.  Around 80% of mitral valves with endocarditis are amnable to repair.  Hospital mortality is around 1-7%.  Recurrent endocarditis is rare after mitral valve repair.  When compared with replacement ,repair of infected mitral valve results in greater freedom from recurrent infection and higher early and late survival.
  • 65.  1. clefts in posterior leaflet  2. with annular calcifications  3. systolic anterior motion  4. Repair of ischemic MR.
  • 66.  Clefts when present in posterior leaflet gets accentuated after the repair  Treatment is approximation of clefts using the mattress suture by prolene 4-0.
  • 67.  Seen mostly in elderly patients and in patients with long standing disease.  There are two sinarios: a) If annulus is not affected by calcification and calcification is only subannular: only partial resection of calcification is required. b) When there is extreme calcification of annular and subannular tissue: separate atria from ventricle and enblock resection of calcium is done followed by reapproximation of atria and ventricle
  • 68.  SAM occurs due use of rigid annuloplasty rings and when the height of the PML is inadequately reduced for repair.  In both of the situations the redundant PML pushes the AML towards the septum in systole and it results in approximation of AML to septum which is enhanced in mid and late systole due to venturi effect leading to LVOTO.
  • 69.
  • 70.  SAM occurs in about 5-10 % cases of repair.  In patients at risk SAM is potentiated by hypovolemia, vasodiatation and use of inotropes.  More events of SAM are seen after quadrangular resection and is minimised by use of sliding plasty.
  • 71.  Treatment of SAM: 1. Reresect the PML to reduce the height. 2. Upsize the annuloplasty ring.
  • 72.  Mechanism of development of MR can be derived from Carpentier’s functional classification.  According to it ischemic MR can result from type I, II, IIIB dysfunctions.  Carpentier’s IIIB dysfunction is most common and significant form of ischemic MR.
  • 73. « Surgeons are not basically concerned with lesions. We care more about function. Therefore one may define the aim of a valve reconstuction as restoring normal leaflet function rather than normal valve anatomy » A. Carpentier, the French Correction 1984
  • 74.  Development of type IIIB dysfunction results due to : 1. Changes in ventricular wall: RWMA, increased sphericity 2. Subvalvar changes includes fibrosis and rupture of papillary muscles, teethering of papillary muscles, apical and posterolateral displcement of papillary muscle leading to restriction of leaflet motion. 3. Annular dilatation and distortion due to alteration in geometry of post infarction LV.
  • 75.  Mechanism can be divided into 3 catagories. 1. Ruptured papillary muscles 2. Infarcted but unruptured papillary muscle lads to fibrosis and chordal elongation. 3. Functional MR: a. Left ventricular dysfunction and dilatation b. Annular dilatation c. Both LV dilatation and annular dilatation.
  • 76. 1. Severe ischemic MR 2. Mild to moderate ischemic MR: Controversial A patient with ischemic MR of grade 2+ onwards require mitral valve repair concomitant with revascularization.
  • 77. 1. Median sternotomy is surgical approach of choice. 2. Right lateral thoracotomy may be used in patients with prior CABG and functioning grafts. Here we perform right anterolateral thoracotomy through 4th ICS. 3. Right thoracotomy is C/I inpatients with previous right thoracic surgeries, COPD, severe AR.
  • 78.  Mitral valve repair is standard treatment for ischemic mitral regurgitation.  Here the anterior paracommissural scallop (P1 ) constitutes the referance point.  Mitral annulus is then examined to access the dilatation.  It is the P2 & P3 segments of posterior leaflet which are most commonly involved as they are attached to posterior papillary muscle which has single blood supply.
  • 79.  Remodeling annuloplasty using undersized ring is the technique of choice in type IIIB dysfunction.  Most commonly braided 2-0 sutures are used to implant the ring.  The anterior commissure is the most difficult area to expose for suture placement and is generally approached last.  Downsizing the physio ring by 1 or 2 sizes or to use a true sized Mc Carthy-Carpentier IMR Etlogix ring is used for annuloplasty.
  • 80.  This IMR ring asymmetrically downsize the annulus .this ring downsizes the D3 dimension by 2 sizes and D2 dimension by 1 size. This makes it possible to select true size ring. Further more this ring contains titanium core which allows complete fixation of septolateral dimension during entire cardiac cycle.
  • 81.
  • 82.  Papillary muscle rupture is managed by mitral valve replacement with bioprosthesis.  Papillary muscle infarction without rupture is managed with repair techniques described with degenerative mitral valve disease and prolapse.  If the portion of posterior leaflet is affected quadrangular resection is indicated.  If there is anterior leaflet prolapse , chordal transfer and chordal replacement suffice.
  • 83.  Hospital mortality after valve repair in ischemic MR is around 3-6%.  5 yr survival is around 58%.  Patients with ruptured papillary muscle have best long term survival , likely due to better preservation of LV function.  Patients with ischemic MR have more damaged LV and correspondingly a reduced longevity.  Because the long term survival is limited the durability of mitral valve repair in patients with ischemic MR is difficult to establish.
  • 84.  Rings can be: 1. Rigid / flexible/ semiflexible 2. Complete/ incomplete/ asymmetric ring Complete ring Incomplete ring 1. CE physio ring(titanium + velor decron) 2. Medtronic complete flexible ring(titanium core with silicon felt, 3 marks for referance.) 3. St jude semiflexible ring (AP angulation) 4. Carbomedics complete flexible ring 1.CE ring made of titanium core. 2. Cogrove C shaped ring. 3. Homemade ring with stainless steel wire.
  • 85.  Choice of ring: 1. Degenerative diseases: rigid or flexible ring. 2. RHD/ endocarditis/ congenital mitral disease: rigid ring. 3. Ischemic MR : rigid ring or asymmetric ring(IMR ring by CE) 4. Functional MR: geoform ring 5. If underlying myocardium is severely diseased the choice is rigid ring and if only valve tissue is involved then incomplete ring is choice.
  • 86.  Rigid rings: there occur no change in diameter of ring in different parts of cardiac cycle. They may interfere with LV filling and functioning, LVOTO.  Incomplete rings: they are used when only annulus is dilated. No support to anterior part of valve .  Semiflexible rings: here the anterior portion is rigid, so no change occurs in transverse diameter. Posterior part is flexible so allows change in transverse diameter of valve.
  • 87.
  • 88. 1. Retain the shape and size of annulus. 2. Keeps tension off the suture lines 3. Increases leaflet coaptation 4. Prevents recurrent dilatation of annulus.
  • 89.  Hospital mortality for isolated first time elective MV repair is 2.5% (males) to 3.9% (females)  Operative risk is higher in elderly pts, associated CABG, NYHA III-IV, low EF and reoperation 100% 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 Replacement Repair Savage EB, et al Ann Thorac Surg 2003;75:820–5
  • 90.  Older age is associated to  Higher mortality  Higher morbidity  Longer LOS  2/3 of pts older than 70 years are denied surgery (Euroheart Survey) Mehta et al. Ann Thorac Surg 2002;74:1459-67
  • 91. Braunberger, et al Circulation. 2001;104[suppl I]:I-8-I-11.
  • 92. Years 100 Survival (%) 80 60 40 20 72% Ejection Fraction EF  60% EF 50-60% 53% EF < 50% 32% P = 0.0001 0 0 2 4 6 8 10 Enriquez-Sarano M et al. Circulation 1994; 90: 830 - 37
  • 93. • If mitral repair is performed before the onset of severe symptoms (congestive heart failure, arrhythmias), life expectancy is restored David T et al, J Thorac Cardiovasc Surg 2003;125:1143-52
  • 94. 1072 patients with degenerative mitral regurgitation operated upon at CCF between 1985 and 1997 Gillinov et alJ Thorac Cardiovasc Surg 1998;116:734-43
  • 95. Flameng W, et al. Circulation. 2003;107:1609-1613